Immune escape of tumors in vivo by expression of cellular FLICE- inhibitory protein

Journal of Experimental Medicine

Volumn 190, Issue 7, 1999, Pages 1033-1038

  Medema, Jan Paul ^a   De Jong, Joan ^a   Van Hall, Thorbald ^a   Melief, Cornelis J M ^a   Offringa, Rienk ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; CD95; CTL; Cytotoxicity; Perforin

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOSURVEILLANCE; LYMPHOCYTOTOXICITY; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ESCAPE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CLONING, MOLECULAR; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; PORE FORMING CYTOTOXIC PROTEINS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0033523670     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.7.1033     Document Type: Article

References (34)

1. Steiler, H. 1995. Mechanisms and genes of cellular suicide. Science. 267:1445-1449.
2. Krammer, P.H. 1999. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71:163-210.
3. Kischkel, F.C., S. Hellbardt, I. Hehrmann, M. Germer, M. Pawlita, P.H. Krammer, and M.E. Peter. 1995. Cytotoxicity-dependent APO-1(Fas/CD95)-associated proteins form a death-inducing signalling complex (DISC) with the receptor. EMBO (Eur. Mol. Biol. Organ.) J. 14:5579-5588.
4. Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:803-816.
5. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, C. Scaffidi, M. Zhang, J. Ni, R. Gentz, M. Mann, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex (DISC). Cell. 85:817-827.
6. Medema, J.P., C. Scaffidi, F.C. Kischkel, A. Shevchenko, M. Mann, P.H. Krammer, and M.E. Peter. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO (Eur. Mol. Biol. Organ.) J. 16:2794-2804.
7. Peter, M.E., C. Scaffidi, J.P. Medema, F. Kischkel, and P.H. Krammer. 1999. The death receptors. Results Probl. Cell Differ. 23:25-63.
8. Medema, J.P., and J. Borst. 1999. T cell signaling: a decision of life and death. Hum. Immunol. 60:403-411.
9. Tschopp, J., M. Irmler, and M. Thome. 1998. Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10:552-558.
10. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature. 388:190-195.
11. Griffith, T.S., W.A. Chin, G.C. Jackson, D.H. Lynch, and M.Z. Kubin. 1998. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol. 161:2833-2840.
12. Melief, C.J. 1992. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 58:143-175.
13. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depreatere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Science. 265:528-530.
14. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature. 370:650-652.
15. Berke, G. 1995. The CTL's kiss of death. Cell. 81:9-12.
16. Medema, J.P., R.E. Toes, C. Scaffidi, T.S. Zheng, R.A. Flaveil, C.J. Melief, M.E. Peter, R. Offringa, and P.H. Krammer. 1997. Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis. Eur. J. Immunol. 27:3492-3498.
17. Kataoka, T., M. Schroter, M. Hahne, P. Schneider, M. Irmler, M. Thome, C.J. Froelich, and J. Tschopp. 1998. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J. Immunol. 161:3936-3942.
18. Jiang, D., and D.C. Flyer. 1992. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection. J. Iimmunol. 148:974-980.
19. Toes, R.E., R. Offringa, R.J. Blom, C.J. Melief, and W.M. Kast. 1996. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc. Natl. Acad. Sci. USA. 93:7855-7860.
20. van den Broek, M.E., D. Kagi, F. Ossendorp, R.E. Toes, S. Vamvakas, W.K. Lutz, C.J. Melief, R.M. Zinkernagel, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781-1790.
21. Medema, J.P., C. Scaffidi, P.H. Krammer, and M.E. Peter. 1998. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J. Biol. Chem. 273: 3388-3393.
22. Kataoka, T., N. Shinohara, H. Takayama, K. Takaku, S. Kondo, S. Yonehara, and K. Nagai. 1996. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cellmediated cytotoxicity. J. Immunol. 156:3678-3686.
23. Peter, M.E., F.C. Kischkel, C.G. Scheuerpflug, J.P. Medema, K.M. Debatin, and P.H. Krammer. 1997. FLICE is involved in regulation of activation-induced cell death (AICD) of peripheral T cells. Eur. J. Immunol. 27:1207-1212.
24. Scaffidi, C., I. Schmitz, P.H. Krammer, and M.E. Peter. 1999. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274:1541-1548.
25. Albert, M.L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:86-89.
26. + T cells by a selfderived peptide. Nature. 378:295-298.
27. Brossart, P., and M.J. Bevan. 1996. Selective activation of Fas/Fas ligand - mediated cytotoxicity by a self peptide. J. Exp. Med. 183:2449-2458.
28. Kessler, B., D. Hudrisier, M. Schroeter, J. Tschopp, J.C. Cerottini, and I.F. Luescher. Peptide modification or blocking of GD8, resulting in weak TCR signaling, can activate CTL for Fas-but not perforin-dependent cytotoxicity or cytokine production. 1998. J. Immunol. 161:6939-6946.
29. Gronbaek, K., P.T. Straten, E. Ralfkiaer, V. Ahrenkiel, M.K. Andersen, N.E. Hansen, J. Zeuthen, K. Hou-Jensen, and P. Guldberg. 1998. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood. 92:3018-3024.
30. Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L.E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, et al. 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science. 274:1363-1366.
31. Strand, S., W.J. Hofmann, H. Hug, M. Muller, G. Otto, D. Strand, S.M. Mariani, W. Stremmel, P.H. Krammer, and P.R. Galle. 1996. Lymphocyte apoptosis induced by CD95 (APO-1/Fas)ligand-expressing tumor cells - a mechanism of immune evasion? Nat. Med. 2:1361-1366.
32. Fenton, R.G., J.A. Hixon, P.W. Wright, A.D. Brooks, and T.J. Sayers. 1998. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras. Cancer Res. 58: 3391-3400.
33. Peli, J., M. Schroter, C. Rudaz, M. Hahne, C. Meyer, E. Reichmann, and J. Tschopp. 1999. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO (Eur. Mol. Biol. Organ.) J. 18:1824-1831.
34. Pitti, R.M., S.A. Marsters, D.A. Lawrence, M. Roy, F.C. Kischkel, P. Dowd, A. Huang, C.J. Donahue, S.W. Sherwood, D.T. Baldwin, et al. 1998. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 396:699-703.